Performance of the NG OligoGen kit for the diagnosis of Neisseria gonorrhoeae: comparison with cobas 4800 assay

被引：0
|
作者：
Parra-Sanchez, M. [1 ]
Garcia-Rey, S. [1 ]
Marcuello, A. [2 ]
Zakariya-Yousef, I. [1 ]
Bernal, S. [1 ]
Pueyo, I. [3 ]
Martin-Mazuelos, E. [1 ]
Palomares, J. C. [1 ]
机构：
[1] Valme Univ Hosp, Unit Infect Dis & Clin Microbiol, Seville, Spain
[2] Operon Inmuno & Mol Diagnost, Zaragoza, Spain
[3] Ctr Sexually Transmitted Infect Seville, Seville, Spain
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 2016年 / 84卷 / 01期
关键词：
Sexually transmitted infections; Neisseria gonorrhoeae; Urine; Diagnostic test; CHLAMYDIA-TRACHOMATIS; CT/NG TEST; SYSTEM; URINE; AGE; DNA;
D O I：
10.1016/j.diagmicrobio.2015.09.020
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
PCR assays are nowadays between the most sensitive and reliable methods for screening and diagnosing sexually transmitted infections (STIs). The aim of this study was to analyze the reliability, accuracy, and usefulness of the new NG OligoGen kit in comparison with the cobas 4800 assay for the detection of Neisseria gonorrhoeae in clinical samples. A prospective study was designed for detection of N. gonorrhoeae including urine samples (n = 152), rectal (n = 80), endocervical (n = 67), pharyngeal (n = 41), and urethral swabs (n = 5) that were sent from a regional STI clinic in Seville, Spain. Samples were collected from 255 (73.9%) men and 90 women. Sensitivity, specificity, positive and negative predicative values, and kappa value for N. gonorrhoeae detection using the NC OligoGen kit were 99.6%, 100%, 100%, 99.1%, and 0.99, respectively. Statistical data obtained in this study confirm the usefulness and reliable results of this new assay. (C) 2016 Elsevier Inc. All rights reserved.
引用
收藏
页码：4 / 6
页数：3
相关论文
共 45 条
  • [41] Prevalence of mutations associated with macrolide and fluoroquinolone resistance in Neisseria gonorrhoeae with AllplexT NG&DR Assay (Seegene®) in a tertiary hospital from Madrid, Spain
    Maldonado-Barrueco, Alfredo
    Sanz-Gonzalez, Claudia
    Falces-Romero, Iker
    Garcia-Clemente, Paloma
    Cacho-Calvo, Juana
    Quiles-Melero, Inmaculada
    REVISTA ESPANOLA DE QUIMIOTERAPIA, 2023, 36 (06) : 625 - 628
  • [42] Novel lateral flow assay for point-of-care detection of Neisseria gonorrhoeae infection in syndromic management settings: a cross-sectional performance evaluation
    Peters, Remco P. H.
    Klausner, Jeffrey D.
    Mazzola, Laura
    Mdingi, Mandisa M.
    Jung, Hyunsul
    Gigi, Ranjana M. S.
    Piton, Jeremie
    Daniels, Joseph
    de Vos, Lindsey
    Adamson, Paul C.
    Gleeson, Birgitta
    Ferreyra, Cecilia
    LANCET, 2024, 403 (10427) : 657 - 664
  • [43] Comparison of an in-house real-time duplex PCR assay with commercial HOLOGIC® APTIMA assays for the detection of Neisseria gonorrhoeae and Chlamydia trachomatis in urine and extra-genital specimens
    Johanna M. E. Venter
    Precious M. Mahlangu
    Etienne E. Müller
    David A. Lewis
    Kevin Rebe
    Helen Struthers
    James McIntyre
    Ranmini S. Kularatne
    BMC Infectious Diseases, 19
  • [44] Comparison of syndromic versus laboratory-confirmed diagnosis of Neisseria gonorrhoeae and Treponema palladium, infections at the selected health centers in Addis Ababa, Ethiopia
    Ayalew, Enaniye
    Fentaw, Surafel
    Ebrahim, Semira
    Seyoum, Elias
    Woldesenbet, Zerihun
    Wolde, Mistire
    REPRODUCTIVE HEALTH, 2022, 19 (01)
  • [45] Performance and acceptability of self-collected specimens for diagnosis of rectal and pharyngeal Chlamydia trachomatis and Neisseria gonorrhoeae infections among men who have sex with men in China: a randomized controlled trial
    Jiang, Ting-Ting
    Cao, Ning-Xiao
    Luo, Wei
    Li, Zheng
    Huang, Zheng-Qiu
    Jia, Tian-Jian
    Yan, Li
    Shi, Mei-Qin
    Han, Yan
    Yin, Yue-Ping
    Chen, Xiang-Sheng
    BMC INFECTIOUS DISEASES, 2024, 24 (01)
12345